Show simple item record

dc.contributor.authorTomasik, Jakub
dc.contributor.authorLago, Santiago G.
dc.contributor.authorVázquez Bourgon, Javier 
dc.contributor.authorPapiol, Sergi
dc.contributor.authorSuárez Pinilla, Paula 
dc.contributor.authorCrespo Facorro, Benedicto 
dc.contributor.authorBahn, Sabine
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2020-07-15T17:17:07Z
dc.date.available2020-07-15T17:17:07Z
dc.date.issued2019-04
dc.identifier.issn2168-622X
dc.identifier.issn2168-6238
dc.identifier.urihttp://hdl.handle.net/10902/18916
dc.description.abstractThis study examines the association between insulin resistance, schizophrenia polygenic risk, and treatment outcomes in first-episode, antipsychotic-naive patients with schizophrenia.es_ES
dc.description.sponsorshipFunding/Support: This work was supported by grants from the Stanley Medical Research Institute (Dr Bahn).es_ES
dc.format.extent10 p.es_ES
dc.language.isoenges_ES
dc.publisherAmerican Medical Association (AMA)es_ES
dc.rights© American Medical Association (AMA)es_ES
dc.sourceJAMA Psychiatry . 2019 Apr 3;76(8):864-867es_ES
dc.titleAssociation of Insulin Resistance With Schizophrenia Polygenic Risk Score and Response to Antipsychotic Treatmentes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://www.doi.org/10.1001/jamapsychiatry.2019.0304es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1001/jamapsychiatry.2019.0304
dc.type.versionpublishedVersiones_ES


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record